camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Keytruda (pembrolizumab) - Merck (MSD)
https://jitc.bmj.com/content/11/Suppl_1/A692
 
Christopher T Chen1; Erika Hamilton2; Patricia LoRusso3; Sylvie Rottey4; Kyriakos P Papadopoulos5; Shivaani Kummar6; Nuria Kotecki7; Fiona C Thistlethwaite8; Yvan LeBruchec9; Jerzy Dyczkowski9; Josef Rüschoff10; Sara Samari11; Marie Toukam12; Joseph Boni12; Karin Havenith11; Serafino Pantano9; Igor Puzanov13
 
Sep 27, 2023
 
Prev Next